Reuters: Regulatory News: FDA staff doubt Cameron device better than rivals

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

FDA staff doubt Cameron device better than rivals Apr 23rd 2012, 14:19 WASHINGTON, April 23 | Mon Apr 23, 2012 10:19am EDT WASHINGTON, April 23 (Reuters) - U.S. medical device reviewers said Cameron Health Inc's defibrillator implanted under the skin may have more infection issues, and work less quickly, than similar devices implanted in the heart. The reviewers from the U.S. Food and Drug Administration also said they would not approve Cameron Health's defibrillator, which treats a dangerously irregular heartbeat, until the company resolved issues with a battery that depletes earlier than it should. The FDA staff review, posted online on Monday, comes ahead of an advisory panel of outside experts, which will vote on the device on Thursday. Boston Scientific Corp agreed to buy Cameron Health Inc in March.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions